for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Alzamend Neuro Inc

ALZN.O

Latest Trade

2.27USD

Change

-0.10(-4.22%)

Volume

1,110,596

Today's Range

2.15

 - 

2.30

52 Week Range

1.87

 - 

33.55

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Alzamend Neuro Receives Positive Results For AL002 In Study

July 23 (Reuters) - Alzamend Neuro Inc <ALZN.O>::ALZAMEND NEURO RECEIVES POSITIVE RESULTS FOR AL002 IN A GLP TOXICOLOGY STUDY USING A TRANSGENIC MOUSE MODEL OF ALZHEIMER’S DISEASE.ALZAMEND NEURO - HISTOPATHOLOGY RESULTS DEMONSTRATE NO INDICATION OF T-CELL INFILTRATION/MENINGOENCEPHALITIS SUGGESTING AL002 IS SAFE AND TOLERABLE.ALZAMEND NEURO - THERE WERE NO TREATMENT-RELATED MORTALITIES/REPORTS OF ADVERSE EFFECTS ON CLINICAL OBSERVATIONS DURING MAIN STUDY/RECOVERY PHASE.

Alzamend Neuro Announces Pricing Of Initial Public Offering

June 14 (Reuters) - Alzamend Neuro Inc <ALZN.O>::ALZAMEND NEURO ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SAYS INITIAL PUBLIC OFFERING OF 2.50 MILLION COMMON SHARES PRICED AT $5.00PER SHARE.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up